{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T02:53:26Z","timestamp":1789872806101,"version":"4.0.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1684\/bdc.2012.1659","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T19:58:43Z","timestamp":1565726323000},"page":"1045-1055","source":"Crossref","is-referenced-by-count":7,"title":["Tumeurs \u00e9pith\u00e9liales thymiques : actualit\u00e9s dans la prise en charge en France"],"prefix":"10.1016","volume":"99","author":[{"given":"Julien","family":"Hadoux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Besse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1684\/bdc.2012.1659_bib0005","series-title":"World Health Organization classification of tumors","article-title":"Pathology and genetics of tumors of the lung, pleura, thymus and heart.","author":"Travis","year":"2004"},{"key":"10.1684\/bdc.2012.1659_bib0010","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"},{"key":"10.1684\/bdc.2012.1659_bib0015","series-title":"7th Cancer Research Workshop","article-title":"Staging and preliminary results of the Thymic Tumour Study Group","author":"Bretel","year":"1989"},{"key":"10.1684\/bdc.2012.1659_bib0020","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/cncr.10226","article-title":"The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients","volume":"94","author":"Okumura","year":"2002","journal-title":"Cancer"},{"key":"10.1684\/bdc.2012.1659_bib0025","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/cncr.10665","article-title":"New WHO histologic classification predicts prognosis of thymic epithelial tumors: a clinicopathologic study of 200 thymoma cases from China","volume":"95","author":"Chen","year":"2002","journal-title":"Cancer"},{"key":"10.1684\/bdc.2012.1659_bib0030","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/0003-4975(95)00669-C","article-title":"Thymoma: a multivariate analysis of factors predicting survival","volume":"60","author":"Blumberg","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"10.1684\/bdc.2012.1659_bib0035","first-page":"173","article-title":"Thymomas and associated diseases. Apropos of a series of 255 surgically treated thymomas","volume":"5","author":"Levasseur","year":"1988","journal-title":"Rev Mal Respir"},{"key":"10.1684\/bdc.2012.1659_bib0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0167-8140(94)01493-M","article-title":"Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. FNCLCC trialists. F\u00e9d\u00e9ration nationale des centres de lutte contre le cancer","volume":"34","author":"Cowen","year":"1995","journal-title":"Radiother Oncol"},{"key":"10.1684\/bdc.2012.1659_bib0045","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0022-5223(96)70265-9","article-title":"Prognostic factors and long-term results after thymoma resection: a series of 307 patients","volume":"112","author":"Regnard","year":"1996","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1684\/bdc.2012.1659_bib0050","first-page":"365","article-title":"Standards, options and recommendations (SOR) for clinical care of malignant thymoma. Groupe de travail SOR","volume":"86","author":"Ruffi\u00e9","year":"1999","journal-title":"Bull Cancer"},{"key":"10.1684\/bdc.2012.1659_bib0055","series-title":"7th Cancer Research Workshop","article-title":"Descriptive epidemiology of thymoma","author":"Exbrayat","year":"1989"},{"key":"10.1684\/bdc.2012.1659_bib0060","doi-asserted-by":"crossref","first-page":"S260","DOI":"10.1097\/JTO.0b013e3181f1f62d","article-title":"Epidemiology of thymoma and associated malignancies","volume":"5","author":"Engels","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1684\/bdc.2012.1659_bib0065","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.hoc.2008.03.004","article-title":"Thymoma, myasthenia gravis, and other paraneoplastic syndromes","volume":"22","author":"Tormoehlen","year":"2008","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1684\/bdc.2012.1659_bib0070","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1007\/s00415-006-0429-z","article-title":"Paraneoplastic diseases associated with thymoma","volume":"254","author":"Evoli","year":"2007","journal-title":"J Neurol"},{"key":"10.1684\/bdc.2012.1659_bib0075","first-page":"136","article-title":"Postoperative radiotherapy for stage I thymoma: a prospective randomized trial in 29 cases","volume":"112","author":"Zhang","year":"1999","journal-title":"Chin Med J"},{"key":"10.1684\/bdc.2012.1659_bib0080","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1097\/JTO.0b013e3181e8f345","article-title":"The role of radiation therapy in malignant thymoma: a surveillance, epidemiology, and end results database analysis","volume":"5","author":"Fernandes","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1684\/bdc.2012.1659_bib0085","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/cncr.10373","article-title":"Postoperative radiotherapy for patients with completely resected thymoma: a multi-institutional, retrospective review of 103 patients","volume":"94","author":"Ogawa","year":"2002","journal-title":"Cancer"},{"key":"10.1684\/bdc.2012.1659_bib0090","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1200\/JCO.1988.6.11.1722","article-title":"Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection","volume":"6","author":"Curran","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2012.1659_bib0095","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0003-4975(10)62558-1","article-title":"Recurrence of thymoma: clinicopathological features, therapy, and prognosis","volume":"39","author":"Monden","year":"1985","journal-title":"Ann Thorac Surg"},{"key":"10.1684\/bdc.2012.1659_bib0100","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0003-4975(03)00819-1","article-title":"Comparison of stages I-II thymoma treated by complete resection with or without adjuvant radiation","volume":"76","author":"Singhal","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1684\/bdc.2012.1659_bib0105","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"10.1684\/bdc.2012.1659_bib0110","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.ijrobp.2009.09.066","article-title":"Role of adjuvant radiotherapy for stage II thymoma after complete tumor resection","volume":"78","author":"Chen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1684\/bdc.2012.1659_bib0115","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1002\/cncr.24618","article-title":"Postoperative radiation therapy after complete resection of thymoma has little impact on survival","volume":"115","author":"Utsumi","year":"2009","journal-title":"Cancer"},{"key":"10.1684\/bdc.2012.1659_bib0120","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0360-3016(96)00086-7","article-title":"Entire hemithorax irradiation following complete resection in patients with stage II-III invasive thymoma","volume":"35","author":"Uematsu","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1684\/bdc.2012.1659_bib0125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/JTO.0b013e31815e8b73","article-title":"Invasive thymoma: postoperative mediastinal irradiation, and low-dose entire hemithorax irradiation in patients with pleural dissemination","volume":"3","author":"Sugie","year":"2008","journal-title":"J Thorac Oncol"},{"issue":"10 suppl. 4","key":"10.1684\/bdc.2012.1659_bib0130","doi-asserted-by":"crossref","first-page":"S323","DOI":"10.1097\/JTO.0b013e3181f20e90","article-title":"Induction therapy for locally advanced thymoma","volume":"5","author":"Riely","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1684\/bdc.2012.1659_bib0135","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1200\/JCO.1999.17.9.2737","article-title":"Treatment of invasive thymoma with single-agent ifosfamide","volume":"17","author":"Highley","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2012.1659_bib0140","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1200\/JCO.1990.8.8.1419","article-title":"Chemotherapy of invasive thymoma","volume":"8","author":"Fornasiero","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2012.1659_bib0145","doi-asserted-by":"crossref","first-page":"6790","DOI":"10.1158\/1078-0432.CCR-09-0644","article-title":"Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas","volume":"15","author":"Girard","year":"2009","journal-title":"Clin Cancer Res"},{"issue":"10 suppl. 4","key":"10.1684\/bdc.2012.1659_bib0150","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.1097\/JTO.0b013e3181f209b9","article-title":"Thymic tumors: relevant molecular data in the clinic","volume":"5","author":"Girard","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1684\/bdc.2012.1659_bib0155","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/cncr.20811","article-title":"Protein expression and gene amplification of epidermal growth factor receptor in thymomas","volume":"103","author":"Ionescu","year":"2005","journal-title":"Cancer"},{"issue":"16 suppl.","key":"10.1684\/bdc.2012.1659_bib0160","first-page":"7068","article-title":"Phase II study of gefitinib treatment in advanced thymic malignancies","volume":"23","author":"Kurup","year":"2005","journal-title":"ASCO Meet Abstr"},{"key":"10.1684\/bdc.2012.1659_bib0165","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/annonc\/mdn388","article-title":"Response of malignant thymoma to erlotinib","volume":"19","author":"Christodoulou","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1684\/bdc.2012.1659_bib0170","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/030089160809400613","article-title":"Erlotinib in advanced well-differentiated thymic carcinoma with overexpression of EGFR: a case report","volume":"94","author":"Pedersini","year":"2008","journal-title":"Tumori"},{"key":"10.1684\/bdc.2012.1659_bib0175","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2741\/2098","article-title":"Cetuximab is an active treatment of metastatic and chemorefractory thymoma","volume":"12","author":"Palmieri","year":"2007","journal-title":"Front Biosci"},{"key":"10.1684\/bdc.2012.1659_bib0180","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1470-2045(07)70141-9","article-title":"Response of thymoma to cetuximab","volume":"8","author":"Farina","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1684\/bdc.2012.1659_bib0185","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1056\/NEJM200406173502523","article-title":"Thymic carcinoma with overexpression of mutated KIT and the response to imatinib","volume":"350","author":"Str\u00f6bel","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1684\/bdc.2012.1659_bib0190","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/JTO.0b013e3181b6be57","article-title":"Imatinib mesylate in patients with WHO B3 thymomas and thymic carcinomas","volume":"4","author":"Giaccone","year":"2009","journal-title":"J Thorac Oncol"},{"key":"10.1684\/bdc.2012.1659_bib0195","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1007\/s005950170021","article-title":"Elevated serum vascular endothelial growth factor and basic fibroblast growth factor levels in patients with thymic epithelial neoplasms","volume":"31","author":"Sasaki","year":"2001","journal-title":"Surg Today"},{"key":"10.1684\/bdc.2012.1659_bib0200","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1067\/mtc.2002.124389","article-title":"Correlation between tumor angiogenesis and invasiveness in thymic epithelial tumors","volume":"124","author":"Tomita","year":"2002","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"15 suppl.","key":"10.1684\/bdc.2012.1659_bib0205","first-page":"19087","article-title":"A phase II trial of erlotinib plus bevacizumab in patients with recurrent thymoma or thymic carcinoma","volume":"26","author":"Bedano","year":"2008","journal-title":"ASCO Meet Abstr"},{"key":"10.1684\/bdc.2012.1659_bib0210","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.1997.15.9.3093","article-title":"Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial","volume":"15","author":"Loehrer","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2012.1659_bib0215","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2003.12.010","article-title":"Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report","volume":"44","author":"Kim","year":"2004","journal-title":"Lung Cancer"},{"key":"10.1684\/bdc.2012.1659_bib0220","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.bjc.6605731","article-title":"A phase II trial of dose-dense chemotherapy, followed by surgical resection and\/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606)","volume":"103","author":"Kunitoh","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1684\/bdc.2012.1659_bib0225","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/sj.bjc.6690773","article-title":"Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience","volume":"81","author":"Berruti","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1684\/bdc.2012.1659_bib0230","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1097\/JTO.0b013e3181db3dee","article-title":"Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma. A French experience","volume":"5","author":"Grassin","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1684\/bdc.2012.1659_bib0235","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/1097-0142(20010601)91:11<2010::AID-CNCR1226>3.0.CO;2-2","article-title":"Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial","volume":"91","author":"Loehrer","year":"2001","journal-title":"Cancer"},{"key":"10.1684\/bdc.2012.1659_bib0240","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","article-title":"Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group","volume":"12","author":"Loehrer","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2012.1659_bib0245","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1200\/JCO.1996.14.3.814","article-title":"Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group","volume":"14","author":"Giaccone","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2012.1659_bib0250","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1200\/JCO.2010.32.9607","article-title":"Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma","volume":"29","author":"Lemma","year":"2011","journal-title":"J Clin Oncol"},{"issue":"18 suppl.","key":"10.1684\/bdc.2012.1659_bib0255","first-page":"7079","article-title":"A phase II trial of pemetrexed in patients with recurrent thymoma or thymic carcinoma","volume":"24","author":"Loehrer","year":"2006","journal-title":"ASCO Meet Abstr"},{"key":"10.1684\/bdc.2012.1659_bib0260","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/00000421-199308000-00014","article-title":"EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma","volume":"16","author":"Bonomi","year":"1993","journal-title":"Am J Clin Oncol"},{"key":"10.1684\/bdc.2012.1659_bib0265","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1200\/JCO.2004.02.047","article-title":"Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group phase II trial","volume":"22","author":"Loehrer","year":"2004","journal-title":"J Clin Oncol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115303763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115303763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T08:30:39Z","timestamp":1602491439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115303763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":53,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0007455115303763"],"URL":"https:\/\/doi.org\/10.1684\/bdc.2012.1659","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}